Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Read user reviews to learn about the best cashback credit cards that don’t charge fees. Make an informed choice!
22,582 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Ford stock rallies on stronger-than-expected results, lifting full-year guidance. ford zooms higher, easily outpacing...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
Celina, Texas leads the nation in growth for a second year, marking a trend toward Texas suburbs where the american d...
Investors eye the long end of the curve as Kevin Warsh's QT stance shifts income dynamics. Forget utility dividends. ...
A potential 18-day walkout by 45,000 Samsung memory workers could disrupt DRAM and high-bandwidth memory supply, send...
Bill Ackman’s Microsoft stake is shifting the AI investing playbook, spotlighting OpenAI ties and geopolitical risk a...
As traditional bonds yield less in a volatile rate environment, retirees are turning to covered-call ETFs such as JEP...
Independent single-family rental owners are largely insulated from institutional competition, according to TurboTenan...
AMD sits near a pivotal $420 level as first-quarter results underscore strong data-center demand and a bold AI-driven...
A rising retirement tactic is gaining traction among mid-career anesthesiologists: tapping 401(K) balances at 55 to c...
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...